Durect Corp
Durect Corp logo
DRRX

Durect Corp (DRRX)

$0.463.77%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$0.46
Day's Range
$0.4804
$0.3601
52-Week Range
$1.67
1 month return0.44%
3 month return16.96%
1 year return68.76%
5 year return73.59%

Company Information

DURECT is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic regulator program. DUR-928, the company's lead drug candidate is in clinical development for the potential treatment of alcohol-associated hepatitis (AH) for which FDA has granted a Fast Track Designation, COVID-19 patients with acute liver or kidney injury, and non-alcoholic steatohepatitis (NASH). DURECT's proprietary drug delivery technologies are designed to enable new indications and enhanced attributes for small-molecule and biologic drugs. One late-stage product candidate in this category is POSIMIR® (bupivacaine sustained-release solution), an investigational locally-acting, non-opioid analgesic intended to provide up to three days of continuous pain relief after surgery.
OrganizationDurect Corp
Employees81
CEOJames Brown
IndustryHealth Technology

Analyst Recommendation

based on 9 analysts ratings

Buy
88%
Buy
11%
Hold
0%
Sell

Based on 9 Wall street analysts offering stock ratings for Durect Corp(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 1150.0%

Current

$0.48

Target

$6.0

Recommendation Trend

Based on 9 analyst

Current1M Ago3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
107.0M
Book Value
0.25
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-0.16
PEG Ratio
-0.46
Wall Street Target Price
5.67

Valuation

Trailing PE0.0
Forward PE0.0
Price/Sales (ttm)
7.66
Price/Book (mrq)
1.87
Enterprise Value
62.4M
Enterprise Value/Revenue
4.46
Enterprise Value/Ebitda
401.35

Technicals

Beta
1.3
50 Day MA
0.59
200 Day MA
0.99

Institutional Holdings

Bleichroeder LP

11.6%

Lion Point Capital, LP

6.8%

BlackRock Inc

6.12%

Vanguard Group Inc

4.96%

Ingalls & Snyder LLC

3.18%

Antara Capital LP

2.01%

Discover more

Frequently Asked Questions

What is Durect Corp share price today?

Can Indians buy Durect Corp shares?

How can I buy Durect Corp shares from India?

Can Fractional shares of Durect Corp be purchased?

What are the documents required to start investing in Durect Corp stocks?

What are today’s High and Low prices of Durect Corp?

What are today’s traded volumes of Durect Corp?

What is today’s market capitalisation of Durect Corp?

What is the 52 Week High and Low Range of Durect Corp?

How much percentage Durect Corp is down from its 52 Week High?

How much percentage Durect Corp is up from its 52 Week low?

What are the historical returns of Durect Corp?

Who is the Chief Executive Officer (CEO) of Durect Corp?